FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology
First Next Generation Sequence Test For Diagnosing | 11/06/2020 | By Darshana | 808
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy